(1S,4S)-4-BENZYL-4-(TERT.-BUTYLDIPHENYLSILYLOXYMETHYL)-2-CYCLOPENTENOL
Compound with spectra: 1 NMR
| SpectraBase Compound ID | EMw5hpUGPjJ |
|---|---|
| InChI | InChI=1S/C29H34O2Si/c1-28(2,3)32(26-15-9-5-10-16-26,27-17-11-6-12-18-27)31-23-29(20-19-25(30)22-29)21-24-13-7-4-8-14-24/h4-20,25,30H,21-23H2,1-3H3/t25-,29+/m1/s1 |
| InChIKey | OWUXYTRZAZPRKV-IRPSRAIASA-N |
| Mol Weight | 442.7 g/mol |
| Molecular Formula | C29H34O2Si |
| Exact Mass | 442.232807 g/mol |
| Enantiomer InChIKey | OWUXYTRZAZPRKV-ABYGYWHVSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
(3Z,5S)-3-((2S)-3-{[tert-Butyl(diphenyl)silyl]oxy}-2-methylpropylidene)-4-[(2S)-pyrrolidinyl]-1,4-pentanediol
.beta.-(tert-Butyldiphenylsilyl)oxymethyl-.beta.-methyl-.alpha.-but-3-enyl-.gamma.-butyrolactone
(2R,3S)-2-[(1-Benzyloxy)cyclopropyl]-3-({[tert-butyl(diphenyl)silyl]oxy}methyl)aziridine
2-[2-[(1E,5E)-9-[[tert-butyl(diphenyl)silyl]oxymethyl]-2,6,10-trimethyl-undeca-1,5-dienyl]-1,3-dioxolan-2-yl]acetic acid ethyl ester
#49;(1-ALPHA,2-BETA,3-BETA)-(+/-)-[(1,1-DIMETHYLETHYL)-DIPHENYL-[[2-[(2-PHENYLMETHOXY)-ETHYL]-3-[(2-METHOXYETHOXY)-METHOXY]-CYCLOPENTYL]-METHYL]-OXY]-SILANE
VDXFWSXOGQJMRH-QXPUDEPPSA-N
2-BENZYL-6-(TERT.-BUTYLDIPHENYLSILYLOXYMETHYL)-PYRIDAZIN-3(2H)-ONE
(2R*,3S*)-1-Benzyloxy-2-(tert-Butyldmethylsiloxy)-8-(tert-butyldiphenylsiloxy)-3,7-dimethyloctane-3-ol
(3S,4R,5R)-6-(tert-Butyldiphenylsilyloxy)-4-(3,4-dimethoxybenzyloxy)-3,5-dimethyl-1-hexene
QJWHSHZVXRVQLD-UHFFFAOYSA-N
| Title | Journal or Book | Year |
|---|---|---|
| Stereoselective Synthesis of 4'-.ALPHA.-Alkylcarbovir Derivatives Based on an Asymmetric Synthesis or Chemoenzymatic Procedure. | Chemical and Pharmaceutical Bulletin | 1999 |
KnowItAll NMR Spectral Library
Author: Wiley
The KnowItAll NMR Spectral Library offers a comprehensive collection of NMR reference spectra, including NMR, CNMR, and XNMR, and covers a wide range of compounds including organics, polymers, monomers, metabolites, and more. Learn more.